DENTSPLY SIRONA Inc (XRAY) SVP Maureen J. Macinnis Sells 54,402 Shares

DENTSPLY SIRONA Inc (NASDAQ:XRAY) SVP Maureen J. Macinnis sold 54,402 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $55.00, for a total value of $2,992,110.00. Following the transaction, the senior vice president now owns 50,962 shares of the company’s stock, valued at approximately $2,802,910. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Shares of NASDAQ XRAY opened at $54.97 on Thursday. The company has a quick ratio of 1.35, a current ratio of 2.06 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $12.84 billion, a P/E ratio of 27.35, a PEG ratio of 2.04 and a beta of 1.11. DENTSPLY SIRONA Inc has a 52-week low of $33.93 and a 52-week high of $55.88.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. The firm had revenue of $946.20 million during the quarter, compared to analyst estimates of $925.13 million. DENTSPLY SIRONA had a positive return on equity of 8.99% and a negative net margin of 26.48%. DENTSPLY SIRONA’s quarterly revenue was down 1.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.45 earnings per share. Analysts anticipate that DENTSPLY SIRONA Inc will post 2.34 EPS for the current year.

Several brokerages have issued reports on XRAY. Zacks Investment Research upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $61.00 target price for the company in a research report on Saturday, May 11th. BidaskClub upgraded DENTSPLY SIRONA from a “buy” rating to a “strong-buy” rating in a research report on Wednesday. Barrington Research upgraded DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $63.00 target price for the company in a research report on Monday, May 6th. ValuEngine upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th. Finally, Guggenheim began coverage on DENTSPLY SIRONA in a research report on Wednesday, April 17th. They set a “neutral” rating and a $54.00 target price for the company. Eight investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $53.65.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Man Group plc raised its stake in DENTSPLY SIRONA by 363.2% in the first quarter. Man Group plc now owns 357,279 shares of the medical instruments supplier’s stock worth $17,717,000 after buying an additional 280,143 shares in the last quarter. M&T Bank Corp raised its stake in DENTSPLY SIRONA by 14.4% in the first quarter. M&T Bank Corp now owns 20,958 shares of the medical instruments supplier’s stock worth $1,039,000 after buying an additional 2,635 shares in the last quarter. C M Bidwell & Associates Ltd. bought a new position in DENTSPLY SIRONA in the first quarter worth approximately $121,000. SEI Investments Co raised its stake in DENTSPLY SIRONA by 19.0% in the first quarter. SEI Investments Co now owns 137,933 shares of the medical instruments supplier’s stock worth $6,836,000 after buying an additional 22,042 shares in the last quarter. Finally, Jefferies Group LLC bought a new position in DENTSPLY SIRONA in the first quarter worth approximately $2,572,000. Hedge funds and other institutional investors own 95.83% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece of content was first reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this piece of content can be viewed at https://www.themarketsdaily.com/2019/05/16/dentsply-sirona-inc-xray-svp-maureen-j-macinnis-sells-54402-shares.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: What is Cost of Capital?

Insider Buying and Selling by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.